Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GenMark Diagnostics Inc (NASDAQ:GNMK)

5.91
Delayed Data
As of Apr 29
 -0.16 / -2.64%
Today’s Change
4.20
Today|||52-Week Range
10.84
-23.84%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$259.7M

Company Description

GenMark Diagnostics, Inc. is a molecular diagnostics company, which is focused on developing and commercializing its proprietary eSensor detection technology. The company's eSensor electrochemical technology enables fast, accurate and highly sensitive detection of multiple distinct biomarkers in a single sample. GenMark Diagnostics was founded by Jon Faiz Kayyem on February 12, 2010 and is headquartered in Carlsbad, CA.

Contact Information

GenMark Diagnostics, Inc.
5964 La Place Court
Carlsbad California 92008-8829
P:(760) 448-4300
Investor Relations:

Employees

Shareholders

Individual stakeholders9.19%
Mutual fund holders57.52%
Other institutional45.50%

Top Executives

Hany MassaranyPresident, Chief Executive Officer & Director
Scott MendelChief Financial Officer
Jon Faiz KayyemSenior Vice President-Research & Development
Eric J. StierSecretary, Senior Vice President & General Counsel
Michael GleesonSenior VP-North American Commercial Operations